These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24433194)

  • 1. Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children.
    Hart JD; Edwards T; Burr SE; Harding-Esch EM; Takaoka K; Holland MJ; Sillah A; Mabey DC; Bailey RL
    Trop Med Int Health; 2014 Feb; 19(2):207-11. PubMed ID: 24433194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
    Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
    Harding-Esch EM; Sillah A; Edwards T; Burr SE; Hart JD; Joof H; Laye M; Makalo P; Manjang A; Molina S; Sarr-Sissoho I; Quinn TC; Lietman T; Holland MJ; Mabey D; West SK; Bailey R;
    PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II).
    Mahmud H; Haile BA; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Liu Z; Callahan EK; Cotter SY; Varnado NE; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Aug; 77(3):388-395. PubMed ID: 37021692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin in control of trachoma.
    Schachter J; West SK; Mabey D; Dawson CR; Bobo L; Bailey R; Vitale S; Quinn TC; Sheta A; Sallam S; Mkocha H; Mabey D; Faal H
    Lancet; 1999 Aug; 354(9179):630-5. PubMed ID: 10466664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL; Arullendran P; Whittle HC; Mabey DC
    Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
    Arzika AM; Mindo-Panusis D; Abdou A; Kadri B; Nassirou B; Maliki R; Alsoudi AF; Zhang T; Cotter SY; Lebas E; O'Brien KS; Callahan EK; Bailey RL; West SK; Goodhew EB; Martin DL; Arnold BF; Porco TC; Lietman TM; Keenan JD;
    JAMA Netw Open; 2022 Aug; 5(8):e2228244. PubMed ID: 35997979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
    Ray KJ; Lietman TM; Porco TC; Keenan JD; Bailey RL; Solomon AW; Burton MJ; Harding-Esch E; Holland MJ; Mabey D
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e458. PubMed ID: 19529761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Alexander ND; Sillah A; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Lancet; 2005 Apr 9-15; 365(9467):1321-8. PubMed ID: 15823382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
    Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
    JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM; Oldenburg CE
    Br J Ophthalmol; 2018 May; 102(5):680-686. PubMed ID: 28893761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Antibiotics for Trachoma: A Cluster-Randomized Trial.
    Melo JS; Aragie S; Chernet A; Tadesse Z; Dagnew A; Hailu D; Haile M; Zeru T; Wittberg DM; Nash SD; Callahan EK; Arnold BF; Porco TC; Lietman TM; Keenan JD
    Clin Infect Dis; 2021 Sep; 73(6):979-986. PubMed ID: 33674869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial.
    Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM
    Am J Trop Med Hyg; 2018 Feb; 98(2):389-395. PubMed ID: 29260659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
    Harding-Esch E; Jofre-Bonet M; Dhanjal JK; Burr S; Edwards T; Holland M; Sillah A; West S; Lietman T; Keenan J; Mabey D; Bailey R
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003670. PubMed ID: 25901349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; Zhou Z; Bailey RL; Mabey DC; Porco TC; Keenan JD; Gaynor BD; West SK; Lietman TM
    Clin Infect Dis; 2017 Mar; 64(6):743-750. PubMed ID: 27956455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When the Neighboring Village is Not Treated: Role of Geographic Proximity to Communities Not Receiving Mass Antibiotics for Trachoma.
    Mosenia A; Haile BA; Shiferaw A; Gebresillasie S; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Callahan EK; Zhou Z; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Mar; 76(6):1038-1042. PubMed ID: 36477547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.